MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze GEHC →
    • FindStock Picks / Stock Screener
    • Value · GEHCIntrinsic Value Calculator
    • Invest · GEHCInvestment Case
    • Hold · GEHC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
GEHC stock logo

GEHC

GE HealthCare Technologies Inc.

$83.02
1.18
 (1.44%)
Exchange:  NASDAQ
Market Cap:  37.536B
Shares Outstanding:  456.522M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – DevicesView industry performance
   
CEO:  Peter J. Arduini
Full Time Employees:  54000
Address: 
500 West Monroe Street
Chicago
IL
60661
US
Website:  https://www.gehealthcare.com
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women’s health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women’s health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

GEHC full analysis

25/06/2025

Welcome to MARKETSNAP’s SWOT analysis for GE HealthCare Technologies, or GEHC as it’s known on the ticker. If you’re a long-term investor looking to build wealth, you’re in the right place. Today, we’re diving deep into what makes GE HealthCare tick, breaking down its strengths, weaknesses, opportunities, and threats. I’ll keep this conversational and packed with insights, so let’s get started with a quick overview of who they are and what’s been happening with this company lately. GE HealthCare Technologies…

Open MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
GEGEHC logoGEHCGE HealthCare Technologies Inc.37.5B17.516.57.8%
DXDXCM logoDXCMDexCom, Inc.31.1B32.230.924.0%
PHPHG logoPHGKoninklijke Philips N.V.29.5B27.216.66.6%
ZBZBH logoZBHZimmer Biomet Holdings, Inc.19.5B26.012.15.3%
GKGKOS logoGKOSGlaukos Corporation14.5B—367-7.2%
EWEW logoEWEdwards Lifesciences Corporation61.6B60.535.59.3%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/10/28 — 3 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue19,552,00019,672,00020,625,000
Gross Profit7,922,0008,205,0008,247,000
EBITDA3,513,0003,666,0003,785,000
Operating Income2,435,0002,625,0002,762,000
Net Income1,568,0001,993,0002,084,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets32,454,00033,089,00036,906,000
Total Liabilities25,144,00024,437,00026,307,000
Total Stockholders Equity7,133,0008,446,00010,379,000
Total Debt9,863,0009,376,000508,000
Cash and Cash Equivalents2,494,0002,874,0004,512,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow2,101,0001,951,0000
Capital Expenditure-387,000-401,000-482,000
Free Cash Flow1,714,0001,550,000-482,000
Net Income1,568,0002,050,0002,154,000
Net Change in Cash1,055,000387,0001,622,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)26,647,270.148Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)27,115,721.297Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)26,880,666.667Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)5,591,298.930Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)5,696,409.280Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)5,643,669.181Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)3,425,225.435Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)3,503,711.353Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)3,464,330.311Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)5,550,364.071Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)5,647,937.834Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)5,598,978.269Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)7.530Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)7.610Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)7.440Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)14Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)3Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
19.672B  ?P/S
 (TTM)
: 
1.73
?Net Income
 (TTM)
: 
1.993B  ?P/E
 (TTM)
: 
17.51
?Enterprise Value
 (TTM)
: 
45.089B  ?EV/FCF
 (TTM)
: 
23.86
?Dividend Yield
 (TTM)
: 
0.18%  ?Payout Ratio
 (TTM)
: 
2.96%
?ROE
 (TTM)
: 
19.85%  ?ROIC
 (TTM)
: 
7.75%
?Net Debt
 (TTM)
: 
6.486B  ?Debt/Equity
 (TTM)
: 
0.9
?P/B
 (TTM)
: 
3.23  ?Current Ratio
 (TTM)
: 
1.3

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
16.54Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

Strengths (preview)

  • Robust Revenue Performance: GEHC has demonstrated consistent revenue growth as reported in recent income statements, with strong gross profit margins (per grossProfitMarginTTM) reflecting operational efficiency. This aligns with positive industry trends in the healthcare equipment and services sector (industryName, sectorName), indicating a competitive position.
  • Solid Cash Flow Generation: High free cash flow (freeCashFlowYieldTTM and freeCashFlow from cash flow statements) underscores GEHC’s ability to fund innovation and capital expenditures (investmentsInPropertyPlantAndEquipment), supporting long-term growth initiatives without over-reliance on external financing.
  • Strong Market Position: As a key player in the healthcare sector (description, sectorName), GEHC benefits from a large market cap (mktCap) and a global presence (revenue from Revenue Geo Segments), providing stability and diversified revenue streams across regions.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Research Access for the complete SWOT analysis.

Create a free account

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates GEHC intrinsic value between $86.18 – $100.62 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate GEHC Intrinsic Value

Common questions about GEHC valuation

Is GE HealthCare Technologies Inc. (GEHC) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for GE HealthCare Technologies Inc. (GEHC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is GEHC a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether GEHC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is GEHC’s P/E ratio?

You can see GEHC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for GEHC?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is GEHC a good long-term investment?

Whether GEHC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for GE HealthCare Technologies Inc.

  • GE HealthCare Technologies Inc. intrinsic value calculatorEstimate what the business is worth
  • GE HealthCare Technologies Inc. 5-year outlookWhat has to go right, and what could go wrong
GEHC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.44
MarketSnap

Trading Metrics:

Open: 82.26   Previous Close: 81.84
Day Low: 81.85   Day High: 83.09
Year Low: 58.75   Year High: 89.77
Price Avg 50: 70.28   Price Avg 200: 69.91
Volume: 2.395M   Average Volume: 4.116M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
13-11-2026 12:41
GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
05-11-2026 13:31
GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
29-10-2026 06:01
GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
GE HealthCare Lifts Forecasts on Healthy Hospital Spending
28-10-2026 13:18
GE HealthCare Lifts Forecasts on Healthy Hospital Spending
GE HealthCare reports third quarter 2026 financial results
28-10-2026 06:20
GE HealthCare reports third quarter 2026 financial results
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
27-10-2026 10:26
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze GEHC →
    • FindStock Picks / Stock Screener
    • Value · GEHCIntrinsic Value Calculator
    • Invest · GEHCInvestment Case
    • Hold · GEHC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.